American Journal of Kidney Diseases
Volume 59, Issue 3 , Pages 364-371, March 2012

Multiple Versus Single and Other Estimates of Baseline Proteinuria Status as Predictors of Adverse Outcomes in the General Population

  • Aminu Bello, MD, PhD

      Affiliations

    • Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
  • ,
  • Stephanie Thompson, MD

      Affiliations

    • Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
  • ,
  • Anita Lloyd, MSc

      Affiliations

    • Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
  • ,
  • Brenda Hemmelgarn, PhD, MD

      Affiliations

    • Department of Medicine, University of Calgary, Calgary, Alberta, Canada
  • ,
  • Scott Klarenbach, MD, MSc

      Affiliations

    • Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
  • ,
  • Braden Manns, MD, MSc

      Affiliations

    • Department of Medicine, University of Calgary, Calgary, Alberta, Canada
  • ,
  • Marcello Tonelli, MD, SM

      Affiliations

    • Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    • Corresponding Author InformationAddress correspondence to Marcello Tonelli, MD, SM, 7-129 Clinical Science Bldg, 8440 112 St, Edmonton, Alberta T6B 2G3, Canada
  • ,
  • Alberta Kidney Disease Network

      Affiliations

    • A list of the members of the Alberta Kidney Disease Network is available at www.akdn.info.

Received 10 June 2011; accepted 10 September 2011. published online 07 November 2011.

Background

The association of proteinuria and adverse clinical outcomes is well established. The optimal method of classifying proteinuria status for study participants in whom it is measured multiple times is unknown, especially when the frequency of measurement varies between participants.

Study Design

Population-based longitudinal study.

Setting & Participants

All adults with at least one outpatient serum creatinine measurement in the province of Alberta, Canada.

Factor

Proteinuria (dipstick, albumin-creatinine ratio [ACR]).

Outcomes

All-cause mortality, end-stage renal disease, or doubling of serum creatinine level.

Measures

All outpatient urine dipstick and ACR measurements in the 6-month period before and after the first (index) estimated glomerular filtration rate were used to establish baseline proteinuria. Dipstick measures were analyzed as ceiling (median value up to the next integer), floor (median value down to the next integer), high (single highest dipstick value), low (single lowest dipstick value), and first (first available dipstick value only). Measurements of ACR were evaluated similarly and a median (median of all ACR measurements) value was added.

Results

Of 920,985 participants, 17% (n = 160,548) had multiple dipstick urinalysis measurements and 22% (n = 22,814) had multiple ACR measurements. With single measurements, absolute rates of mortality and renal outcomes were lower in every proteinuria category compared with multiple measurements. In contrast, the relative increase in rate ratio was greater with increasing proteinuria in patients with single measurements compared with those with multiple measurements. In all classification systems evaluated, more severe proteinuria was associated with significantly higher rates of both outcomes (all P for trend <0.001).

Limitations

Lack of a gold standard for choosing between methods.

Conclusions

Rates of adverse outcomes related to multiple baseline proteinuria/albuminuria measurements were similar, independent of the measure of baseline proteinuria that was used to combine results. In contrast, discarding follow-up measurements and relying on only the first measurement led to lower estimates of absolute and relative risk for each proteinuria category.

Index Words:  Proteinuria , measurements , adverse outcomes , population

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Originally published online November 7, 2011.

PII: S0272-6386(11)01325-4

doi:10.1053/j.ajkd.2011.09.006

American Journal of Kidney Diseases
Volume 59, Issue 3 , Pages 364-371, March 2012